Dyskinesia, Drug-Induced (pathology) < Dyskinesia, Drug-Induced (physiopathology) < Dyskinesia, Drug-Induced (prevention & control)

Facettes :

List of bibliographic references indexed by Dyskinesia, Drug-Induced (physiopathology)

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000424 (2016)	Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]	Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
000592 (2015)	Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]	Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000800 (2015)	Rafael Godoy [Canada] ; Sandra Noble [Canada] ; Kevin Yoon [Canada] ; Hymie Anisman [Canada] ; Marc Ekker [Canada]	Chemogenetic ablation of dopaminergic neurons leads to transient locomotor impairments in zebrafish larvae.
000C43 (2013)	Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie	The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.
000C92 (2013)	Vincent A. Jourdain [Canada] ; Laurent Grégoire ; Marc Morissette ; Nicolas Morin ; Martin Parent ; Thérèse Di Paolo	Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy.
000D92 (2013)	Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Michel Panisset [Canada] ; Christian Duval [Canada]	Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?
001123 (2012)	Laure Chagniel [Canada] ; Christine Robitaille ; Manon Lebel ; Michel Cyr	Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model.
001268 (2012)	Rena K. Mann [Canada] ; Roderick Edwards ; Julie Zhou ; Alison Fenney ; Mandar Jog ; Christian Duval	Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia.
001679 (2011)	James K R. Stevenson [Canada] ; Pouria Talebifard ; Edna Ty ; Meeko M K. Oishi ; Martin J. Mckeown	Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication.
001720 (2011)	Benoit Carignan [Canada] ; Jean-François Daneault ; Christian Duval	Assessing drug-induced dyskinesia in the clinic, the laboratory and the natural environment of patients.
001723 (2011)	Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. Brotchie	Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?
001996 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie	Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001A28 (2010)	Rena K. Mann [Canada] ; Roderick Edwards ; Julie Zhou ; Mandar Jog ; Christian Duval	Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease.
002158 (2008)	Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie	Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
002380 (2008)	Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada]	Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea
002455 (2007)	Jackie Gour [Canada] ; Roderick Edwards ; Sarah Lemieux ; Mehrdad Ghassemi ; Mandar Jog ; Christian Duval	Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
002805 (2006)	Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]	Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin
002822 (2006)	Francesca Morgante [Canada] ; Alberto J. Espay [Canada] ; Carolyn Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]	Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias
002914 (2006)	Carl Julien [Canada] ; Line Berthiaume [Canada] ; Abdallah Hadj-Tahar [Canada] ; Ali H. Rajput [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] ; Pierre Julien [Canada] ; Frédéric Calon [Canada]	Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys
002975 (2005)	J M Brotchie [Canada] ; J. Lee ; K. Venderova	Levodopa-induced dyskinesia in Parkinson's disease.
002A41 (2005)	Jonathan M. Brotchie [Canada]	Nondopaminergic mechanisms in levodopa‐induced dyskinesia

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dyskinesia, Drug-Induced (physiopathology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dyskinesia, Drug-Induced (physiopathology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia, Drug-Induced (physiopathology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022